{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T11:25:39Z","timestamp":1793013939670,"version":"4.5.0"},"reference-count":215,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:00:00Z","timestamp":1710460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Shaanxi Fundamental Science Research Project for Chemistry and Biology","award":["22JHQ084"],"award-info":[{"award-number":["22JHQ084"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Colorectal cancer (CRC), a prevalent malignant tumor of the digestive system, ranks as the third and second in global incidence and mortality, respectively, in 2020, with 1.93 million new cases (\u224810% of all cancers). There are 940,000 deaths (\u22489.4% of all cancers), and the incidence of CRC in younger patients (under 50 years of age) has become a new trend. The pathogenesis of CRC is primarily attributed to a series of genetic and epigenetic abnormalities within normal colonic epithelial cells, coupled with the reshaping of the tumor microenvironment in the surrounding stroma. This process leads to the transformation of colorectal adenomas into invasive adenocarcinomas. Although genetic changes are known to be the primary driving force in the occurrence and progression of CRC, recent research indicates that epigenetic regulation serves as a crucial molecular marker in cancer, playing a significant role in the pathological and physiological control of interactions between genetics and the environment. This review discusses the current global epidemiology of CRC, its risk factors, and preventive treatment strategies. The current study explores the latest advancements in the epigenetic regulation of CRC, including DNA methylation, histone modifications, and non-coding RNAs (ncRNAs). These developments hold potential as screening tools, prognostic biomarkers, and therapeutic targets for CRC.<\/jats:p>","DOI":"10.3390\/ijms25063358","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T12:02:39Z","timestamp":1710504159000},"page":"3358","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Epigenetic Alteration in Colorectal Cancer: Potential Diagnostic and Prognostic Implications"],"prefix":"10.3390","volume":"25","author":[{"given":"Qing","family":"Cao","sequence":"first","affiliation":[{"name":"Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Northwest University, Xi\u2019an 710069, China"},{"name":"Provincial Key Laboratory of Biotechnology of Shaanxi Province, Northwest University, Xi\u2019an 710069, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Tian","sequence":"additional","affiliation":[{"name":"Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Northwest University, Xi\u2019an 710069, China"},{"name":"Provincial Key Laboratory of Biotechnology of Shaanxi Province, Northwest University, Xi\u2019an 710069, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4681-9480","authenticated-orcid":false,"given":"Zhiyi","family":"Deng","sequence":"additional","affiliation":[{"name":"Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Northwest University, Xi\u2019an 710069, China"},{"name":"Provincial Key Laboratory of Biotechnology of Shaanxi Province, Northwest University, Xi\u2019an 710069, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Yang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Northwest University, Xi\u2019an 710069, China"},{"name":"Provincial Key Laboratory of Biotechnology of Shaanxi Province, Northwest University, Xi\u2019an 710069, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9168-7407","authenticated-orcid":false,"given":"Erfei","family":"Chen","sequence":"additional","affiliation":[{"name":"Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Northwest University, Xi\u2019an 710069, China"},{"name":"Provincial Key Laboratory of Biotechnology of Shaanxi Province, Northwest University, Xi\u2019an 710069, China"},{"name":"School of Medicine, Northwest University, Xi\u2019an 710069, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,3,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3389\/fmed.2018.00234","article-title":"Tumor heterogeneity in primary colorectal cancer and corresponding metastases. Does the apple fall far from the tree?","volume":"5","author":"Blank","year":"2018","journal-title":"Front. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","first-page":"89","article-title":"Epidemiology of colorectal cancer: Incidence, mortality, survival, and risk factors","volume":"14","author":"Rawla","year":"2019","journal-title":"Przegl\u0105d Gastroenterol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/CM9.0000000000001474","article-title":"Changing profiles of cancer burden worldwide and in china: A secondary analysis of the global cancer statistics 2020","volume":"134","author":"Cao","year":"2021","journal-title":"Chin. Med. J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ymeth.2020.06.022","article-title":"Modern epigenetics methods in biological research","volume":"187","author":"Li","year":"2021","journal-title":"Methods"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-981-15-3449-2_1","article-title":"Epigenetics in health and disease","volume":"1253","author":"Zhang","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/cam4.2004","article-title":"Long noncoding rna and mrna profiling in cetuximab-resistant colorectal cancer cells by rna sequencing analysis","volume":"8","author":"Jing","year":"2019","journal-title":"Cancer Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-I","article-title":"A genetic model for colorectal tumorigenesis","volume":"61","author":"Fearon","year":"1990","journal-title":"Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3892\/ol.2014.2815","article-title":"Quantitative detection of methylated ndrg4 gene as a candidate biomarker for diagnosis of colorectal cancer","volume":"9","author":"Xiao","year":"2015","journal-title":"Oncol. Lett."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00384-020-03757-x","article-title":"DNA methylation markers detected in blood, stool, urine, and tissue in colorectal cancer: A systematic review of paired samples","volume":"36","author":"Laugsand","year":"2020","journal-title":"Int. J. Color. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergencyto.2010.05.018","article-title":"Development of a multiplex methylight assay for the detection of multigene methylation in human colorectal cancer","volume":"202","author":"He","year":"2010","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000500639","article-title":"Stool-based mir-92a and mir-144* as noninvasive biomarkers for colorectal cancer screening","volume":"97","author":"Choi","year":"2019","journal-title":"Oncology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.celrep.2019.08.105","article-title":"Reduction of global h3k27me3 enhances her2\/erbb2 targeted therapy","volume":"29","author":"Hirukawa","year":"2019","journal-title":"Cell Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1158\/2159-8290.CD-19-0463","article-title":"Histone lysine methylation dynamics controlegfrdna copy-number amplification","volume":"10","author":"Clarke","year":"2020","journal-title":"Cancer Discov."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1136\/gutjnl-2014-308392","article-title":"Long non-coding rna ccal regulates colorectal cancer progression by activating wnt\/\u03b2-catenin signalling pathway via suppression of activator protein 2\u03b1","volume":"65","author":"Ma","year":"2016","journal-title":"Gut"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/s41575-019-0189-8","article-title":"Global burden of colorectal cancer: Emerging trends, risk factors and prevention strategies","volume":"16","author":"Keum","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3892\/ijo.2013.2041","article-title":"Precancerous colorectal lesions","volume":"43","author":"Conteduca","year":"2013","journal-title":"Int. J. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM198809013190901","article-title":"Genetic alterations during colorectal-tumor development","volume":"319","author":"Vogelstein","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Hossain, M.S., Karuniawati, H., Jairoun, A.A., Urbi, Z., Ooi, D.J., John, A., Lim, Y.C., Kibria, K.M.K., Mohiuddin, A.K.M., and Ming, L.C. (2022). Colorectal cancer: A review of carcinogenesis, global epidemiology, current challenges, risk factors, preventive and treatment strategies. Cancers, 14.","DOI":"10.3390\/cancers14071732"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1053\/j.gastro.2020.01.004","article-title":"Risk factors for early-onset colorectal cancer","volume":"159","author":"Low","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/jnci\/djj468","article-title":"Association of smoking, cpg island methylator phenotype, and v600e braf mutations in colon cancer","volume":"98","author":"Samowitz","year":"2006","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.3748\/wjg.v29.i10.1569","article-title":"Systemic treatment for metastatic colorectal cancer","volume":"29","author":"Leowattana","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Kryczka, J., Sochacka, E., Papiewska-Paj\u0105k, I., and Boncela, J. (2020). Implications of abcc4\u2013mediated camp efflux for crc migration. Cancers, 12.","DOI":"10.3390\/cancers12123547"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"609","DOI":"10.21037\/atm.2019.07.91","article-title":"Concise update on colorectal cancer epidemiology","volume":"7","author":"Mattiuzzi","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3322\/caac.21395","article-title":"Colorectal cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41575-022-00736-1","article-title":"Therapeutic landscape and future direction of metastatic colorectal cancer","volume":"20","author":"Bando","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1056\/NEJMoa1908075","article-title":"Encorafenib, binimetinib, and cetuximab in braf v600e\u2013mutated colorectal cancer","volume":"381","author":"Kopetz","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1634\/theoncologist.2019-0129","article-title":"Safety of nivolumab plus low-dose ipilimumab in previously treated microsatellite instability-high\/mismatch repair-deficient metastatic colorectal cancer","volume":"24","author":"Morse","year":"2019","journal-title":"Oncologist"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.2174\/0929867324666170111152436","article-title":"Colorectal cancer chemotherapy: The evolution of treatment and new approaches","volume":"24","author":"McQuade","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1056\/NEJMoa0804385","article-title":"K-ras mutations and benefit from cetuximab in advanced colorectal cancer","volume":"359","author":"Karapetis","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1056\/NEJMoa033025","article-title":"Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer","volume":"351","author":"Cunningham","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1200\/JCO.2007.14.7116","article-title":"Wild-type kras is required for panitumumab efficacy in patients with metastatic colorectal cancer","volume":"26","author":"Amado","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S1470-2045(14)70118-4","article-title":"Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type kras exon 2 metastatic colorectal cancer (aspecct): A randomised, multicentre, open-label, non-inferiority phase 3 study","volume":"15","author":"Price","year":"2014","journal-title":"Lancet Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S1470-2045(16)00150-9","article-title":"Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, kras codon 12\/13 wild-type, her2-positive metastatic colorectal cancer (heracles): A proof-of-concept, multicentre, open-label, phase 2 trial","volume":"17","author":"Trusolino","year":"2016","journal-title":"Lancet Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/cncr.29986","article-title":"Activity of the oral mitogen-activated protein kinase kinase inhibitor trametinib in ras-mutant relapsed or refractory myeloid malignancies","volume":"122","author":"Borthakur","year":"2016","journal-title":"Cancer"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"103663","DOI":"10.1016\/j.critrevonc.2022.103663","article-title":"Latest evidence on immune checkpoint inhibitors in metastatic colorectal cancer: A 2022 update","volume":"173","author":"Boukouris","year":"2022","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S1470-2045(17)30422-9","article-title":"Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (checkmate 142): An open-label, multicentre, phase 2 study","volume":"18","author":"Overman","year":"2017","journal-title":"Lancet Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"Pd-1 blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","article-title":"Pembrolizumab in microsatellite-instability\u2013high advanced colorectal cancer","volume":"383","author":"Shiu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1158\/0008-5472.CAN-23-0628","article-title":"Brcaness, homologous recombination deficiencies, and synthetic lethality","volume":"83","author":"Murai","year":"2023","journal-title":"Cancer Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":"Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer","volume":"350","author":"Hurwitz","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S1470-2045(13)70154-2","article-title":"Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (avex): An open-label, randomised phase 3 trial","volume":"14","author":"Cunningham","year":"2013","journal-title":"Lancet Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1200\/JCO.2012.42.8201","article-title":"Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase iii randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen","volume":"30","author":"Tabernero","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(12)61900-X","article-title":"Regorafenib monotherapy for previously treated metastatic colorectal cancer (correct): An international, multicentre, randomised, placebo-controlled, phase 3 trial","volume":"381","author":"Grothey","year":"2013","journal-title":"Lancet"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.cell.2007.01.033","article-title":"The mammalian epigenome","volume":"128","author":"Bernstein","year":"2007","journal-title":"Cell"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.chembiol.2015.11.007","article-title":"Nucleic acid modifications in regulation of gene expression","volume":"23","author":"Chen","year":"2016","journal-title":"Cell Chem. Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.cell.2015.04.018","article-title":"N6-methyladenine DNA modification in drosophila","volume":"161","author":"Zhang","year":"2015","journal-title":"Cell"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1126\/science.1063852","article-title":"The role of DNA methylation in mammalian epigenetics","volume":"293","author":"Jones","year":"2001","journal-title":"Science"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/humrep\/dep015","article-title":"DNA methyltransferase expression in the human endometrium: Down-regulation by progesterone and estrogen","volume":"24","author":"Yamagata","year":"2009","journal-title":"Hum. Reprod."},{"key":"ref_50","first-page":"460","article-title":"DNA methylation and hypertension: Emerging evidence and challenges","volume":"15","author":"Han","year":"2016","journal-title":"Brief. Funct. Genomics"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.biocel.2015.05.022","article-title":"Epigenetic dynamics in immunity and autoimmunity","volume":"67","author":"Zhao","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1053\/j.gastro.2015.07.011","article-title":"Epigenetic alterations in colorectal cancer: Emerging biomarkers","volume":"149","author":"Okugawa","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10555-010-9207-6","article-title":"DNA methylation markers in colorectal cancer","volume":"29","author":"Kim","year":"2010","journal-title":"Cancer Metastasis Rev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s13148-018-0578-9","article-title":"Comprehensive methylation analysis of imprinting-associated differentially methylated regions in colorectal cancer","volume":"10","author":"Hidaka","year":"2018","journal-title":"Clin. Epigenetics"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1042\/EBC20190030","article-title":"Enhancer DNA methylation: Implications for gene regulation","volume":"63","author":"Blewitt","year":"2019","journal-title":"Essays Biochem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.molcel.2019.06.045","article-title":"Dynamic enhancer DNA methylation as basis for transcriptional and cellular heterogeneity of escs","volume":"75","author":"Song","year":"2019","journal-title":"Mol. Cell"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1101\/gr.197194.115","article-title":"Enhancer methylation dynamics contribute to cancer plasticity and patient mortality","volume":"26","author":"Bell","year":"2016","journal-title":"Genome Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1371\/journal.pgen.0030157","article-title":"Comparing the DNA hypermethylome with gene mutations in human colorectal cancer","volume":"3","author":"Schuebel","year":"2007","journal-title":"PLoS Genet."},{"key":"ref_59","first-page":"28","article-title":"Novel sulindac derivatives for colorectal cancer chemoprevention that target cGMP phosphodiesterases to suppress Wnt\/\u03b2-catenin transcriptional activity","volume":"3","author":"Ramesh","year":"2024","journal-title":"Cancer Insight"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"46468","DOI":"10.18632\/oncotarget.17576","article-title":"APC hypermethylation for early diagnosis of colorectal cancer: A meta-analysis and literature review","volume":"8","author":"Liang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_61","first-page":"e18","article-title":"Aberrant methylation of the ptch1 gene promoter region in aberrant crypt foci","volume":"132","author":"Peng","year":"2012","journal-title":"Int. J. Cancer"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"7416","DOI":"10.1073\/pnas.92.16.7416","article-title":"Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas","volume":"92","author":"Yoshiura","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/annonc\/mdn782","article-title":"MGMT and MLH1 promoter methylation versus APC, KRAS and BRAF gene mutations in colorectal cancer: Indications for distinct pathways and sequence of events","volume":"20","author":"Weijenberg","year":"2009","journal-title":"Ann. Oncol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s10495-014-1022-z","article-title":"DNA methylation of apoptosis genes in rectal cancer predicts patient survival and tumor recurrence","volume":"19","author":"Benard","year":"2014","journal-title":"Apoptosis"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"21","DOI":"10.58567\/ci02010007","article-title":"E3 ubiquitin ligase-dependent regulatory mechanism of TRIM family in carcinogenesis","volume":"2","author":"Zhang","year":"2023","journal-title":"Cancer Insight"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/35057062","article-title":"Initial sequencing and analysis of the human genome","volume":"409","author":"Lander","year":"2001","journal-title":"Nature"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1128\/MCB.21.6.1973-1985.2001","article-title":"Antisense promoter of human L1 retrotransposon drives transcription of adjacent cellular genes","volume":"21","author":"Speek","year":"2023","journal-title":"Mol. Cell Biol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e00369","DOI":"10.14309\/ctg.0000000000000369","article-title":"Correlation of line-1 hypomethylation with size and pathologic extent of dysplasia in colorectal tubular adenomas","volume":"12","author":"Jiang","year":"2021","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Boughanem, H., Martin-Nu\u00f1ez, G.M., Torres, E., Arranz-Salas, I., Alcaide, J., Morcillo, S., Tinahones, F.J., Crujeiras, A.B., and Macias-Gonzalez, M. (2020). Impact of tumor line-1 methylation level and neoadjuvant treatment and its association with colorectal cancer survival. J. Pers. Med., 10.","DOI":"10.3390\/jpm10040219"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Matsunoki, A., Kawakami, K., Kotake, M., Kaneko, M., Kitamura, H., Ooi, A., Watanabe, G., and Minamoto, T. (2012). LINE-1 methylation shows little intra-patient heterogeneity in primary and synchronous metastatic colorectal cancer. BMC Cancer, 12.","DOI":"10.1186\/1471-2407-12-574"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"784","DOI":"10.7150\/ijbs.6.784","article-title":"S-adenosylmethionine inhibits the growth of cancer cells by reversing the hypomethylation status of c-myc and H-ras in human gastric cancer and colon cancer","volume":"6","author":"Luo","year":"2010","journal-title":"Int. J. Biol. Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/ijc.11176","article-title":"Role of hmlh1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines","volume":"106","author":"Arnold","year":"2003","journal-title":"Int. J. Cancer"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13148-023-01546-1","article-title":"Crispr\/dcas9-mediated DNA demethylation screen identifies functional epigenetic determinants of colorectal cancer","volume":"15","author":"Tejedor","year":"2023","journal-title":"Clin. Epigenetics"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1158\/1055-9965.EPI-17-0153","article-title":"Stool DNA test of methylated syndecan-2 for the early detection of colorectal neoplasia","volume":"26","author":"Niu","year":"2017","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Zhang, L., Dong, L., Lu, C., Huang, W., Yang, C., Wang, Q., Wang, Q., Lei, R., Sun, R., and Wan, K. (2021). Methylation of sdc2\/tfpi2 and its diagnostic value in colorectal tumorous lesions. Front. Mol. Biosci., 8.","DOI":"10.3389\/fmolb.2021.706754"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1038\/ctg.2016.66","article-title":"Diagnostic accuracy of methylated sept9 for blood-based colorectal cancer detection: A systematic review and meta-analysis","volume":"8","author":"Nian","year":"2017","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/jnci\/dji204","article-title":"Detection in fecal DNA of colon cancer\u2013specific methylation of the nonexpressed vimentin gene","volume":"97","author":"Chen","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/ajg.2011.6","article-title":"Methylation of neurog1 in serum is a sensitive marker for the detection of early colorectal cancer","volume":"106","author":"Herbst","year":"2011","journal-title":"Am. J. Gastroenterol."},{"key":"ref_79","first-page":"1225","article-title":"Detection of promoter hypermethylation in serum samples of cancer patients by methylation-specific polymerase chain reaction for tumour suppressor genes including RUNX3","volume":"18","author":"Tan","year":"2007","journal-title":"Oncol. Rep."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/ijc.26484","article-title":"DNA methylation patterns in blood of patients with colorectal cancer and adenomatous colorectal polyps","volume":"131","author":"Cassinotti","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.canlet.2011.07.006","article-title":"Detection of tfpi2 methylation in the serum of colorectal cancer patients","volume":"311","author":"Hibi","year":"2011","journal-title":"Cancer Lett."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1158\/0008-5472.CAN-08-0142","article-title":"Methylation oftfpi2in stool DNA: A potential novel biomarker for the detection of colorectal cancer","volume":"69","author":"Dhir","year":"2009","journal-title":"Cancer Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13148-021-01076-8","article-title":"Sensitive detection of colorectal cancer in peripheral blood by a novel methylation assay","volume":"13","author":"Zhang","year":"2021","journal-title":"Clin. Epigenetics"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/cam4.273","article-title":"Aberrant promoter methylation of ppp1r3c and efhd1 in plasma of colorectal cancer patients","volume":"3","author":"Takane","year":"2014","journal-title":"Cancer Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1016\/j.ygeno.2020.06.007","article-title":"Identifying potential DNA methylation markers in early-stage colorectal cancer","volume":"112","author":"Zhang","year":"2020","journal-title":"Genomics"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3816\/CCC.2010.n.023","article-title":"Novel methylation panel for the early detection of colorectal tumors in stool DNA","volume":"9","author":"Azuara","year":"2010","journal-title":"Clin. Color. Cancer"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1158\/1940-6207.CAPR-12-0501","article-title":"DNA methylation biomarkers for noninvasive diagnosis of colorectal cancer","volume":"6","author":"Carmona","year":"2013","journal-title":"Cancer Prev. Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jmoldx.2013.03.004","article-title":"Genome-wide identification and validation of a novel methylation biomarker, sdc2, for blood-based detection of colorectal cancer","volume":"15","author":"Oh","year":"2013","journal-title":"J. Mol. Diagn."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3389\/fonc.2018.00247","article-title":"Diagnostic value of methylated septin9 for colorectal cancer detection","volume":"8","author":"Xie","year":"2018","journal-title":"Front. Oncol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1136\/gutjnl-2012-304149","article-title":"Prospective evaluation of methylatedsept9in plasma for detection of asymptomatic colorectal cancer","volume":"63","author":"Church","year":"2014","journal-title":"Gut"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/jgh.12855","article-title":"Performance of a second-generation methylated sept9 test in detecting colorectal neoplasm","volume":"30","author":"Jin","year":"2015","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/jnci\/djp131","article-title":"N-myc downstream-regulated gene 4 (ndrg4): A candidate tumor suppressor gene and potential biomarker for colorectal cancer","volume":"101","author":"Melotte","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Weitzman, J., Kim, M.S., Louwagie, J., Carvalho, B., Terhaar sive Droste, J.S., Park, H.L., Chae, Y.K., Yamashita, K., Liu, J., and Ostrow, K.L. (2009). Promoter DNA methylation of oncostatin m receptor-\u03b2 as a novel diagnostic and therapeutic marker in colon cancer. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0006555"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1002\/ijc.30565","article-title":"Diagnostic and prognostic role of cell-free DNA testing for colorectal cancer patients","volume":"140","author":"Bedin","year":"2017","journal-title":"Int. J. Cancer"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1158\/1940-6207.CAPR-11-0315","article-title":"DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements fit","volume":"5","author":"Bosch","year":"2012","journal-title":"Cancer Prev. Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"E88","DOI":"10.25011\/cim.v34i1.15105","article-title":"Diagnostic and prognostic value of the methylation status of secreted frizzled-related protein 2 in colorectal cancer","volume":"34","author":"Tang","year":"2011","journal-title":"Clin. Investig. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1007\/s10620-007-9755-y","article-title":"Hypermethylation of sfrp2 as a potential marker for stool-based detection of colorectal cancer and precancerous lesions","volume":"52","author":"Huang","year":"2007","journal-title":"Dig. Dis. Sci."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"230","DOI":"10.7150\/ijms.5278","article-title":"Detection of hypermethylated spastic paraplegia-20 in stool samples of patients with colorectal cancer","volume":"10","author":"Zhang","year":"2013","journal-title":"Int. J. Med. Sci."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1111\/j.1572-0241.2005.50412.x","article-title":"Quantitative detection of promoter hypermethylation in multiple genes in the serum of patients with colorectal cancer","volume":"100","author":"Leung","year":"2005","journal-title":"Am. J. Gastroenterol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3748\/wjg.v13.i6.950","article-title":"Detection of aberrant methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions","volume":"13","author":"Huang","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cgh.2006.10.006","article-title":"Improved fecal DNA test for colorectal cancer screening","volume":"5","author":"Itzkowitz","year":"2007","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jmoldx.2011.12.003","article-title":"Detection of hypermethylated vimentin in urine of patients with colorectal cancer","volume":"14","author":"Song","year":"2012","journal-title":"J. Mol. Diagn."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"6185","DOI":"10.1158\/1078-0432.CCR-09-0111","article-title":"Aberrant methylation of apc, mgmt, rassf2a, and wif-1 genes in plasma as a biomarker for early detection of colorectal cancer","volume":"15","author":"Lee","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/jnci\/djp265","article-title":"Analysis of fecal DNA methylation to detect gastrointestinal neoplasia","volume":"101","author":"Nagasaka","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1007\/DCR.0b013e3181a79533","article-title":"Stool methylation-specific polymerase chain reaction assay for the detection of colorectal neoplasia in korean patients","volume":"52","author":"Baek","year":"2009","journal-title":"Dis. Colon. Rectum"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","article-title":"Chromatin modifications and their function","volume":"128","author":"Kouzarides","year":"2007","journal-title":"Cell"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/1756283X16671287","article-title":"Targeting histone methylation for colorectal cancer","volume":"10","author":"Huang","year":"2017","journal-title":"Ther. Adv. Gastroenterol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.humpath.2011.07.009","article-title":"Global histone modification of histone h3 in colorectal cancer and its precursor lesions","volume":"43","author":"Nakazawa","year":"2012","journal-title":"Hum. Pathol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ejso.2013.02.023","article-title":"Global histone modification of h3k27 correlates with the outcomes in patients with metachronous liver metastasis of colorectal cancer","volume":"39","author":"Tamagawa","year":"2013","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/cas.12166","article-title":"Cancer-associated upregulation of histone h3 lysine 9 trimethylation promotes cell motility in vitro and drives tumor formation in vivo","volume":"104","author":"Yokoyama","year":"2013","journal-title":"Cancer Sci."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.yexmp.2015.03.011","article-title":"Rgc-32 is a novel regulator of the t-lymphocyte cell cycle","volume":"98","author":"Tegla","year":"2015","journal-title":"Exp. Mol. Pathol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.yexmp.2009.10.010","article-title":"Epigenetic modifications induced by rgc-32 in colon cancer","volume":"88","author":"Vlaicu","year":"2010","journal-title":"Exp. Mol. Pathol."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Mao, Q.D., Zhang, W., Zhao, K., Cao, B., Yuan, H., Wei, L.Z., Song, M.Q., and Liu, X.S. (2017). Microrna-455 suppresses the oncogenic function of hdac2 in human colorectal cancer. Braz. J. Med. Biol. Res., 50.","DOI":"10.1590\/1414-431x20176103"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s13046-020-01783-9","article-title":"Hdac2 inhibits emt-mediated cancer metastasis by downregulating the long noncoding rna h19 in colorectal cancer","volume":"39","author":"Hu","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1111\/j.1582-4934.2009.00832.x","article-title":"Autophagy inhibition enhances vorinostat-induced apoptosis via ubiquitinated protein accumulation","volume":"14","author":"Carew","year":"2009","journal-title":"J. Cell Mol. Med."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1053\/j.gastro.2020.06.050","article-title":"Tp63, sox2, and klf5 establish a core regulatory circuitry that controls epigenetic and transcription patterns in esophageal squamous cell carcinoma cell lines","volume":"159","author":"Jiang","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrc.2017.99","article-title":"Non-coding rna networks in cancer","volume":"18","author":"Anastasiadou","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature11233","article-title":"Landscape of transcription in human cells","volume":"489","author":"Djebali","year":"2012","journal-title":"Nature"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.3390\/molecules19056080","article-title":"Issues and prospects of microrna-based biomarkers in blood and other body fluids","volume":"19","author":"Chevillet","year":"2014","journal-title":"Molecules"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Ali Syeda, Z., Langden, S.S.S., Munkhzul, C., Lee, M., and Song, S.J. (2020). Regulatory mechanism of microrna expression in cancer. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21051723"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.cell.2009.02.005","article-title":"MicroRNAs and cancer: Short RNAs go a long way","volume":"136","author":"Ventura","year":"2009","journal-title":"Cell"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mrfmmm.2011.03.009","article-title":"Microrna history: Discovery, recent applications, and next frontiers","volume":"717","author":"Almeida","year":"2011","journal-title":"Mutat. Res."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1242\/dmm.027441","article-title":"Micrornas in the etiology of colorectal cancer: Pathways and clinical implications","volume":"10","author":"Strubberg","year":"2017","journal-title":"Dis. Model. Mech."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/onc.2008.474","article-title":"Role of mir-143 targeting kras in colorectal tumorigenesis","volume":"28","author":"Chen","year":"2009","journal-title":"Oncogene"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1136\/gutjnl-2014-308455","article-title":"Novel evidence for an oncogenic role of microRNA-21 in colitis-associated colorectal cancer","volume":"65","author":"Shi","year":"2016","journal-title":"Gut"},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Lai, C.-Y., Yeh, K.-Y., Liu, B.-F., Chang, T.-M., Chang, C.-H., Liao, Y.-F., Liu, Y.-W., and Her, G.M. (2021). Microrna-21 plays multiple oncometabolic roles in colitis-associated carcinoma and colorectal cancer via the pi3k\/akt, stat3, and pdcd4\/tnf-\u03b1 signaling pathways in zebrafish. Cancers, 13.","DOI":"10.3390\/cancers13215565"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"106","DOI":"10.18869\/acadpub.ibj.21.2.106","article-title":"Investigation of microrna-21 expression levels in serum and stool as a potential non-invasive biomarker for diagnosis of colorectal cancer","volume":"21","author":"Bastaminejad","year":"2017","journal-title":"Iran. Biomed. J."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/hmg\/10.7.721","article-title":"The ABC of APC","volume":"10","author":"Fearnhead","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"5795","DOI":"10.1158\/0008-5472.CAN-08-0951","article-title":"Regulation of the adenomatous polyposis coli gene by the mir-135 family in colorectal cancer","volume":"68","author":"Nagel","year":"2008","journal-title":"Cancer Res."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4149\/neo_2019_190401N282","article-title":"Mir-429 as biomarker for diagnosis, treatment and prognosis of cancers and its potential action mechanisms: A systematic literature review","volume":"67","author":"Guo","year":"2020","journal-title":"Neoplasma"},{"key":"ref_131","first-page":"218","article-title":"Mir-429 mediates tumor growth and metastasis in colorectal cancer","volume":"7","author":"Han","year":"2017","journal-title":"Am. J. Cancer Res."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.2147\/OTT.S104729","article-title":"Effect of evodiamine and berberine on mir-429 as an oncogene in human colorectal cancer","volume":"9","author":"Liu","year":"2016","journal-title":"OncoTargets Ther."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"e659","DOI":"10.1038\/cddis.2013.193","article-title":"Mir-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer","volume":"4","author":"Karaayvaz","year":"2013","journal-title":"Cell Death Dis."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.3748\/wjg.v23.i10.1816","article-title":"Mir-34a mediates oxaliplatin resistance of colorectal cancer cells by inhibiting macroautophagy via transforming growth factor-\u03b2\/smad4 pathway","volume":"23","author":"Sun","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.molonc.2013.09.001","article-title":"Plasma micrornas predicting clinical outcome in metastatic colorectal cancer patients receiving first-line oxaliplatin-based treatment","volume":"8","author":"Kjersem","year":"2014","journal-title":"Mol. Oncol."},{"key":"ref_136","first-page":"4944","article-title":"Mir-106a reduces 5-fluorouracil (5-fu) sensitivity of colorectal cancer by targeting dual-specificity phosphatases 2 (dusp2)","volume":"24","author":"Qin","year":"2018","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"ref_137","first-page":"4207","article-title":"Differential expression of dusp2 in left- and right-sided colon cancer is associated with poor prognosis in colorectal cancer","volume":"15","author":"Dong","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.4161\/cbt.6.8.4486","article-title":"DNA methylation regulates microrna expression","volume":"6","author":"Han","year":"2007","journal-title":"Cancer Biol. Ther."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13046-019-1059-5","article-title":"Microrna-34 family: A potential tumor suppressor and therapeutic candidate in cancer","volume":"38","author":"Zhang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"13556","DOI":"10.1073\/pnas.0803055105","article-title":"A microrna DNA methylation signature for human cancer metastasis","volume":"105","author":"Lujambio","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1756-8722-5-58","article-title":"Expression of mir-34 is lost in colon cancer which can be re-expressed by a novel agent cdf","volume":"5","author":"Roy","year":"2012","journal-title":"J. Hematol. Oncol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"52983","DOI":"10.18632\/oncotarget.17677","article-title":"Mir-133b down-regulates abcc1 and enhances the sensitivity of crc to anti-tumor drugs","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"8363","DOI":"10.1111\/jcmm.15282","article-title":"Serum mir-92a-1 is a novel diagnostic biomarker for colorectal cancer","volume":"24","author":"Shi","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/ijc.25007","article-title":"Plasma micrornas are promising novel biomarkers for early detection of colorectal cancer","volume":"127","author":"Huang","year":"2010","journal-title":"Int. J. Cancer"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/gut.2008.167817","article-title":"Differential expression of micrornas in plasma of patients with colorectal cancer: A potential marker for colorectal cancer screening","volume":"58","author":"Ng","year":"2009","journal-title":"Gut"},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Silva, C.M.S., Barros-Filho, M.C., Wong, D.V.T., Mello, J.B.H., Nobre, L.M.S., Wanderley, C.W.S., Lucetti, L.T., Muniz, H.A., Paiva, I.K.D., and Kuasne, H. (2021). Circulating let-7e-5p, mir-106a-5p, mir-28-3p, and mir-542-5p as a promising microrna signature for the detection of colorectal cancer. Cancers, 13.","DOI":"10.3390\/cancers13071493"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"118417","DOI":"10.1016\/j.lfs.2020.118417","article-title":"Identification of stool mir-135b-5p as a non-invasive diaognostic biomarker in later tumor stage of colorectal cancer","volume":"260","author":"Li","year":"2020","journal-title":"Life Sci."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/jnci\/djt101","article-title":"Serum mir-21 as a diagnostic and prognostic biomarker in colorectal cancer","volume":"105","author":"Toiyama","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s13353-016-0379-9","article-title":"Plasma and saliva mir-21 expression in colorectal cancer patients","volume":"58","author":"Sazanov","year":"2017","journal-title":"J. Appl. Genet."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1245\/s10434-022-12355-w","article-title":"Identification of the minimum combination of serum micrornas to predict the recurrence of colorectal cancer cases","volume":"30","author":"Yoshikawa","year":"2022","journal-title":"Ann. Surg. Oncol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.18632\/oncotarget.13766","article-title":"Diagnostic and prognostic value of mir-106a in colorectal cancer","volume":"8","author":"Hao","year":"2017","journal-title":"Oncotarget"},{"key":"ref_152","first-page":"4197","article-title":"Serum mir-106b upregulation predicts poor prognosis in patients with colorectal cancer","volume":"11","author":"Zhao","year":"2018","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_153","first-page":"3352","article-title":"The clinical significance of mir-429 as a predictive biomarker in colorectal cancer patients receiving 5-fluorouracil treatment","volume":"22","author":"Dong","year":"2016","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3892\/mco.2013.61","article-title":"Plasma mir-200c and mir-18a as potential biomarkers for the detection of colorectal carcinoma","volume":"1","author":"Zhang","year":"2013","journal-title":"Mol. Clin. Oncol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"10663","DOI":"10.18632\/oncotarget.7119","article-title":"Microrna-223 and microrna-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection","volume":"7","author":"Chang","year":"2016","journal-title":"Oncotarget"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3233\/CBM-182171","article-title":"Expression levels of mir-143-3p and -424-5p in colorectal cancer and their clinical significance","volume":"24","author":"Kheirandish","year":"2019","journal-title":"Cancer Biomark."},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Xu, L., Li, M., Wang, M., Yan, D., Feng, G., and An, G. (2014). The expression of microrna-375 in plasma and tissue is matched in human colorectal cancer. BMC Cancer, 14.","DOI":"10.1186\/1471-2407-14-714"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.2147\/CMAR.S238492","article-title":"Diagnostic value of combining mirnas, cea measurement and the fobt in colorectal cancer screening","volume":"12","author":"Li","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13046-015-0198-6","article-title":"Plasma levels of microrna-24, microrna-320a, and microrna-423-5p are potential biomarkers for colorectal carcinoma","volume":"34","author":"Fang","year":"2015","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.18632\/oncotarget.6403","article-title":"Microrna-20a in human faeces as a non-invasive biomarker for colorectal cancer","volume":"7","author":"Yau","year":"2016","journal-title":"Oncotarget"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1038\/bjc.2014.484","article-title":"Microrna-221 and microrna-18a identification in stool as potential biomarkers for the non-invasive diagnosis of colorectal carcinoma","volume":"111","author":"Yau","year":"2014","journal-title":"Br. J. Cancer"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3233\/CBM-150563","article-title":"Fecal mir-29a and mir-224 as the noninvasive biomarkers for colorectal cancer","volume":"16","author":"Zhu","year":"2016","journal-title":"Cancer Biomark."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/jama.299.4.425","article-title":"Microrna expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma","volume":"299","author":"Schetter","year":"2008","journal-title":"JAMA"},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Ray, R.B., Uratani, R., Toiyama, Y., Kitajima, T., Kawamura, M., Hiro, J., Kobayashi, M., Tanaka, K., Inoue, Y., and Mohri, Y. (2016). Diagnostic potential of cell-free and exosomal micrornas in the identification of patients with high-risk colorectal adenomas. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0160722"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s12032-013-0781-7","article-title":"The expression of mir-25 is increased in colorectal cancer and is associated with patient prognosis","volume":"31","author":"Li","year":"2013","journal-title":"Med. Oncol."},{"key":"ref_166","first-page":"2417","article-title":"Mir-1260b is a potential prognostic biomarker in colorectal cancer","volume":"22","author":"Liu","year":"2016","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Cheng, H., Zhang, L., Cogdell, D.E., Zheng, H., Schetter, A.J., Nykter, M., Harris, C.C., Chen, K., Hamilton, S.R., and Zhang, W. (2011). Circulating plasma mir-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0017745"},{"key":"ref_168","first-page":"2097","article-title":"Tumor microrna-29a expression and the risk of recurrence in stage ii colon cancer","volume":"40","author":"Kushnir","year":"2012","journal-title":"Int. J. Oncol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/j.canep.2011.05.002","article-title":"Serum microrna-29a is a promising novel marker for early detection of colorectal liver metastasis","volume":"36","author":"Wang","year":"2012","journal-title":"Cancer Epidemiol."},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Aherne, S.T., Madden, S.F., Hughes, D.J., Pardini, B., Naccarati, A., Levy, M., Vodicka, P., Neary, P., Dowling, P., and Clynes, M. (2015). Circulating mirnas mir-34a and mir-150 associated with colorectal cancer progression. BMC Cancer, 15.","DOI":"10.1186\/s12885-015-1327-5"},{"key":"ref_171","first-page":"95","article-title":"Differential expression of serum mir-126, mir-141 and mir-21 as novel biomarkers for early detection of liver metastasis in colorectal cancer","volume":"26","author":"Yin","year":"2014","journal-title":"Chin. J. Cancer Res."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1089\/omi.2012.0132","article-title":"Mir-429 identified by dynamic transcriptome analysis is a new candidate biomarker for colorectal cancer prognosis","volume":"18","author":"Sun","year":"2014","journal-title":"OMICS J. Integr. Biol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.molcel.2011.08.018","article-title":"Molecular mechanisms of long noncoding rnas","volume":"43","author":"Wang","year":"2011","journal-title":"Mol. Cell"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41556-019-0311-8","article-title":"Cellular functions of long noncoding rnas","volume":"21","author":"Yao","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.canlet.2015.03.002","article-title":"Long noncoding rnas: Novel players in colorectal cancer","volume":"361","author":"Han","year":"2015","journal-title":"Cancer Lett."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/nm.3981","article-title":"The emerging role of lncrnas in cancer","volume":"21","author":"Huarte","year":"2015","journal-title":"Nat. Med."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12943-018-0873-2","article-title":"Lncrna dleu1 contributes to colorectal cancer progression via activation of kpna3","volume":"17","author":"Liu","year":"2018","journal-title":"Mol. Cancer"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"8526","DOI":"10.1080\/21655979.2022.2051839","article-title":"Upregulated long intergenic non-protein coding rna 1094 (linc01094) is linked to poor prognosis and alteration of cell function in colorectal cancer","volume":"13","author":"Zhang","year":"2022","journal-title":"Bioengineered"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13046-021-01911-z","article-title":"Correction to: Long non-coding rna h19 promotes colorectal cancer metastasis via binding to hnrnpa2b1","volume":"40","author":"Zhang","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"8365","DOI":"10.2147\/IJGM.S393270","article-title":"Upregulation of long noncoding rna malat1 in colorectal cancer promotes radioresistance and aggressive malignance","volume":"15","author":"Shen","year":"2022","journal-title":"Int. J. Gen. Med."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.abb.2019.01.005","article-title":"Lncrna cacs15 contributes to oxaliplatin resistance in colorectal cancer by positively regulating abcc1 through sponging mir-145","volume":"663","author":"Gao","year":"2019","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1186\/s12935-021-02353-5","article-title":"Long noncoding rna crart16 confers 5-fu resistance in colorectal cancer cells by sponging mir-193b-5p","volume":"21","author":"Wang","year":"2021","journal-title":"Cancer Cell Int."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12935-020-1155-9","article-title":"The novel long noncoding rna crart16 confers cetuximab resistance in colorectal cancer cells by enhancing erbb3 expression via mir-371a-5p","volume":"20","author":"Zhang","year":"2020","journal-title":"Cancer Cell Int."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1016\/j.bbadis.2018.05.020","article-title":"Functional role of a long non-coding rna lifr-as1\/mir-29a\/tnfaip3 axis in colorectal cancer resistance to pohotodynamic therapy","volume":"1864","author":"Liu","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s12033-021-00444-2","article-title":"Long non-coding rna cbr3 antisense rna 1 is downregulated in colorectal cancer and inhibits mir-29a-mediated cell migration and invasion","volume":"64","author":"Yang","year":"2022","journal-title":"Mol. Biotechnol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/bjc.2013.724","article-title":"Microrna-29a promotes colorectal cancer metastasis by regulating matrix metalloproteinase 2 and e-cadherin via klf4","volume":"110","author":"Tang","year":"2014","journal-title":"Br. J. Cancer"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"11026","DOI":"10.1080\/21655979.2022.2067292","article-title":"The role of long non-coding rna fgd5-as1 in cancer","volume":"13","author":"He","year":"2022","journal-title":"Bioengineered"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s11626-019-00376-x","article-title":"Long noncoding rna fgd5-as1 promotes colorectal cancer cell proliferation, migration, and invasion through upregulating cdca7 via sponging mir-302e","volume":"55","author":"Li","year":"2019","journal-title":"In Vitro Cell Dev. Biol. Anim."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.3892\/or.2013.2633","article-title":"Epigenetic silencing of mir-126 contributes to tumor invasion and angiogenesis in colorectal cancer","volume":"30","author":"Zhang","year":"2013","journal-title":"Oncol. Rep."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3389\/fgene.2019.00880","article-title":"Linc00460 hypomethylation promotes metastasis in colorectal carcinoma","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Genet."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.bbagen.2017.12.001","article-title":"Hotair-mediated reciprocal regulation of ezh2 and dnmt1 contribute to polyphyllin i-inhibited growth of castration-resistant prostate cancer cells in vitro and in vivo","volume":"1862","author":"Xiang","year":"2018","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/1751-2980.12712","article-title":"Fecal occult blood test in colorectal cancer screening","volume":"20","author":"Li","year":"2019","journal-title":"J. Dig. Dis."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.biopha.2017.12.058","article-title":"Lncrna hif1a-as2 positively affects the progression and emt formation of colorectal cancer through regulating mir-129-5p and dnmt3a","volume":"98","author":"Lin","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1136\/gutjnl-2020-322780","article-title":"Nucleatum targets lncrna eno1-it1 to promote glycolysis and oncogenesis in colorectal cancer","volume":"70","author":"Hong","year":"2021","journal-title":"Gut"},{"key":"ref_195","doi-asserted-by":"crossref","unstructured":"Alvandi, E., Wong, W.K.M., Joglekar, M.V., Spring, K.J., and Hardikar, A.A. (2022). Short-chain fatty acid concentrations in the incidence and risk-stratification of colorectal cancer: A systematic review and meta-analysis. BMC Med., 20.","DOI":"10.1186\/s12916-022-02529-4"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1190810","DOI":"10.3389\/fimmu.2023.1190810","article-title":"Short chain fatty acids prime colorectal cancer cells to activate antitumor immunity","volume":"14","author":"Mowat","year":"2023","journal-title":"Front. Immunol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/jn\/132.5.1012","article-title":"The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation","volume":"132","author":"Hinnebusch","year":"2002","journal-title":"J. Nutr."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"612826","DOI":"10.3389\/fimmu.2021.612826","article-title":"Immune system, microbiota, and microbial metabolites: The unresolved triad in colorectal cancer microenvironment","volume":"12","author":"Hanus","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_199","doi-asserted-by":"crossref","unstructured":"Ma, Y., Liu, X., and Wang, J. (2022). Small molecules in the big picture of gut microbiome-host cross-talk. EBioMedicine, 81.","DOI":"10.1016\/j.ebiom.2022.104085"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1093\/annonc\/mdx248","article-title":"Ccat1 and ccat2 long noncoding rnas, located within the 8q.24.21 \u2018gene desert\u2019, serve as important prognostic biomarkers in colorectal cancer","volume":"28","author":"Ozawa","year":"2017","journal-title":"Ann. Oncol."},{"key":"ref_201","first-page":"7042","article-title":"Two novel long noncoding rnas\u2014rp11-296e3.2 and lef1-as1can\u2014Separately serve as diagnostic and prognostic bio-markers of metastasis in colorectal cancer","volume":"25","author":"Shi","year":"2019","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.7754\/Clin.Lab.2019.190412","article-title":"Prognostic significance and diagnostic value of overexpressed lncrna pvt1 in colorectal cancer","volume":"65","author":"Pan","year":"2019","journal-title":"Clin. Lab."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.7754\/Clin.Lab.2020.200805","article-title":"High expression of long noncoding rna 01410 serves as a potential diagnostic and prognostic marker in patients with colorectal cancer","volume":"67","author":"Xu","year":"2021","journal-title":"Clin Lab."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3233\/CBM-170179","article-title":"Elevated serum level of lncrna-hif1a-as1 as a novel diagnostic predictor for worse prognosis in colorectal carcinoma","volume":"20","author":"Gong","year":"2017","journal-title":"Cancer Biomark."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"618967","DOI":"10.3389\/fonc.2021.618967","article-title":"Circulating serum exosomal long non-coding rnas foxd2-as1, nrir, and xloc_009459 as diagnostic biomarkers for colorectal cancer","volume":"11","author":"Yu","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_206","doi-asserted-by":"crossref","unstructured":"Liu, S., Cao, Q., An, G., Yan, B., and Lei, L. (2020). Identification of the 3-lncrna signature as a prognostic biomarker for colorectal cancer. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21249359"},{"key":"ref_207","doi-asserted-by":"crossref","unstructured":"Brenner, H., Stock, C., and Hoffmeister, M. (2015). Colorectal cancer screening: The time to act is now. BMC Med., 13.","DOI":"10.1186\/s12916-015-0498-x"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1007\/s10350-004-6810-z","article-title":"Prediagnostic levels of carcinoembryonic antigen and ca 242 in colorectal cancer: A matched case-control study","volume":"46","author":"Palmqvist","year":"2003","journal-title":"Dis. Colon Rectum"},{"key":"ref_209","first-page":"556","article-title":"Carcinoembryonic antigen screening: Pros and cons","volume":"26","author":"Macdonald","year":"1999","journal-title":"Semin. Oncol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJMoa1300720","article-title":"Long-term mortality after screening for colorectal cancer","volume":"369","author":"Shaukat","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1053\/j.gastro.2018.03.062","article-title":"Effectiveness of colorectal cancer screening in detecting earlier-stage disease-a nationwide cohort study in Denmark","volume":"155","author":"Larsen","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1158\/1078-0432.CCR-15-1268","article-title":"Evaluation of a 5-marker blood test for colorectal cancer early detection in a colorectal cancer screening setting","volume":"22","author":"Werner","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"441","DOI":"10.7326\/0003-4819-149-7-200810070-00004","article-title":"Stool DNA and occult blood testing for screen detection of colorectal neoplasia","volume":"149","author":"Ahlquist","year":"2008","journal-title":"Ann. Intern. Med."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1311194","article-title":"Multitarget stool DNA testing for colorectal-cancer screening","volume":"370","author":"Imperiale","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1266\/ggs.21-00102","article-title":"ANRIL as a prognostic biomarker in colon pre-cancerous lesion detection via non-invasive sampling","volume":"96","author":"Sadri","year":"2022","journal-title":"Genes Genet. Syst."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/6\/3358\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:14:28Z","timestamp":1760105668000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/6\/3358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,15]]},"references-count":215,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["ijms25063358"],"URL":"https:\/\/doi.org\/10.3390\/ijms25063358","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,15]]}}}